blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2091611

EP2091611 - NEW DRUG FOR TREATING GASTRIC CANCER [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.11.2012
Database last updated on 14.11.2024
Most recent event   Tooltip02.11.2012Application deemed to be withdrawnpublished on 05.12.2012  [2012/49]
Applicant(s)For all designated states
BIOMERIEUX
Chemin de l'Orme
69280 Marcy-L'Etoile / FR
For all designated states
Hospices Civils de Lyon
3, Quai des Célestins
69002 Lyon / FR
[2009/35]
Inventor(s)01 / MIOSSEC, Pierre
16, rue de Reims
F-69500 Bron / FR
02 / TOH, Myew-Ling
53, cours de la Liberté
F-69003 Lyon / FR
 [2009/35]
Representative(s)Sarlin, Laure V., et al
Cabinet Beau de Loménie
51, avenue Jean-Jaurès
BP 7073
69301 Lyon Cedex 07 / FR
[N/P]
Former [2010/44]Sarlin, Laure V., et al
Cabinet Beau de Loménie 51, avenue Jean-Jaurès BP 7073
69301 Lyon Cedex 07 / FR
Former [2009/45]Bitaud, Valérie Marie-Odile, et al
BioMérieux, Département Propriété Industrielle Chemin de l'Orme
69280 Marcy l'Etoile / FR
Former [2009/35]Denjean, Frédérique
bioMérieux Service Propriété Industrielle Chemin de l'Orme
F-69280 Marcy l'Etoile / FR
Application number, filing date07871986.120.12.2007
[2009/35]
WO2007FR52575
Priority number, dateFR2006005583521.12.2006         Original published format: FR 0655835
[2009/35]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2008087329
Date:24.07.2008
Language:FR
[2008/30]
Type: A2 Application without search report 
No.:EP2091611
Date:26.08.2009
Language:FR
The application published by WIPO in one of the EPO official languages on 24.07.2008 takes the place of the publication of the European patent application.
[2009/35]
Search report(s)International search report - published on:EP27.11.2008
ClassificationIPC:A61P35/00, A61K39/395, C12N15/11
[2009/35]
CPC:
C07K14/54 (EP,US); A61P35/00 (EP); C07K14/7155 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/35]
TitleGerman:NEUES ARZNEIMITTEL ZUR BEHANDLUNG VON MAGENKREBS[2009/35]
English:NEW DRUG FOR TREATING GASTRIC CANCER[2009/35]
French:NOUVEAU MÉDICAMENT POUR LE TRAITEMENT D'UN CANCER GASTRIQUE[2009/35]
Entry into regional phase26.05.2009National basic fee paid 
26.05.2009Designation fee(s) paid 
26.05.2009Examination fee paid 
Examination procedure26.05.2009Examination requested  [2009/35]
11.05.2010Despatch of a communication from the examining division (Time limit: M06)
28.09.2010Reply to a communication from the examining division
06.02.2012Despatch of a communication from the examining division (Time limit: M04)
19.06.2012Application deemed to be withdrawn, date of legal effect  [2012/49]
20.07.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/49]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.05.2010
Fees paidRenewal fee
19.11.2009Renewal fee patent year 03
08.10.2010Renewal fee patent year 04
19.12.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2006054059  (UCB CELLTECH [GB], et al) [X] 1-4,6-9,11 * page 2, lines 24,25 * * page 26, line 11 *;
 [X]WO2006088833  (WYETH CORP [US], et al) [X] 6-10 * paragraphs [0154] - [0156]; claims 8-22 *;
 [X]  - YOU ZONGBING ET AL, "Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer", CANCER RESEARCH, (200601), vol. 66, no. 1, ISSN 0008-5472, pages 175 - 183, XP002442246 [X] 6-10 * abstract * * page 175, column R, paragraph 4 - page 176, column R, paragraph 4 *

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-05-1130
 [A]  - MIZUNO T ET AL, "Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization", WORLD JOURNAL OF GASTROENTEROLOGY 28 OCT 2005 CHINA, (20051028), vol. 11, no. 40, ISSN 1007-9327, pages 6305 - 6311, XP009086507 [A] 1-5,11 * page 6305, column R, paragraph 2 * * page 6306, column L, paragraph 1 * * page 6310, column R, paragraph 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.